Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Receptive Language Skills Among Young Children in Rural Guatemala: The Relationship Between the Test de Vocabulario en Imagenes Peabody and a Translated and Adapted Version of the Mullen Scales of Early Learning.

Connery AK, Colbert AM, Lamb MM, Hernández S, Martínez MA, Bauer D, Arroyave P, El Sahly HM, Paniagua-Avila A, Calvimontes M, Bolaños GA, Olson D, Asturias EJ, Munoz FM.

Child Care Health Dev. 2019 Jul 3. doi: 10.1111/cch.12702. [Epub ahead of print]

PMID:
31270836
2.

Hepatic abscesses due to Clostridium septicum infection and its association with colonic adenocarcinoma: a case report and literature review.

Manwani B, Xu Y, El Sahly HM.

Clin J Gastroenterol. 2019 Jun 12. doi: 10.1007/s12328-019-01002-9. [Epub ahead of print]

PMID:
31190186
3.

The Reply.

El Chaer F, El Sahly HM.

Am J Med. 2019 May 31. pii: S0002-9343(19)30424-3. doi: 10.1016/j.amjmed.2019.04.038. [Epub ahead of print] No abstract available.

PMID:
31153868
4.

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

El Sahly HM, Atmar RL, Patel SM, Bellamy A, Liu L, Hong W, Zhu H, Guan Y, Keitel WA; DMID 13-0033 Vaccine Study Group.

Vaccine. 2019 May 1;37(19):2561-2568. doi: 10.1016/j.vaccine.2019.03.071. Epub 2019 Apr 4.

PMID:
30955980
5.

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.

El Sahly HM, Gorchakov R, Lai L, Natrajan MS, Patel SM, Atmar RL, Keitel WA, Hoft DF, Barrett J, Bailey J, Edupuganti S, Raabe V, Wu HM, Fairley J, Rouphael N, Murray KO, Mulligan MJ.

Open Forum Infect Dis. 2018 Dec 19;6(1):ofy352. doi: 10.1093/ofid/ofy352. eCollection 2019 Jan.

6.

Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity.

El Chaer F, El Sahly HM.

Am J Med. 2019 Apr;132(4):437-446. doi: 10.1016/j.amjmed.2018.12.011. Epub 2019 Jan 3. Review.

PMID:
30611828
7.

Responding to the Zika Epidemic: Preparation of a Neurodevelopmental Testing Protocol to Evaluate Young Children in Rural Guatemala.

Connery AK, Berrios-Siervo G, Arroyave P, Bauer D, Hernandez S, Paniagua-Avila A, Bolaños GA, Bunge-Montes S, El Sahly HM, Calvimontes M, Olson D, Munoz FM, Asturias EJ.

Am J Trop Med Hyg. 2019 Feb;100(2):438-444. doi: 10.4269/ajtmh.18-0713.

PMID:
30594262
8.

Optimizing PCR Detection of Zika Virus from Various Body Fluids.

Gorchakov R, Berry RM, Patel SM, El Sahly HM, Ronca SE, Murray KO.

Am J Trop Med Hyg. 2019 Feb;100(2):427-433. doi: 10.4269/ajtmh.18-0755.

9.

Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis.

Schwarz C, Brandt C, Melichar V, Runge C, Heuer E, Sahly H, Schebek M, Köster H, Bouchara JP, Biedermann T, Meißner P, Große-Onnebrink J, Skopnik H, Hartl D, Sedlacek L, Tintelnot K.

J Cyst Fibros. 2019 Mar;18(2):227-232. doi: 10.1016/j.jcf.2018.08.012. Epub 2018 Oct 6.

PMID:
30297214
10.

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Jackson LA, El Sahly HM, George S, Winokur P, Edwards K, Brady RC, Rouphael N, Keitel WA, Mulligan MJ, Burton RL, Nakamura A, Ferreria J, Nahm MH.

Vaccine. 2018 Jan 29;36(5):606-614. doi: 10.1016/j.vaccine.2017.12.061. Epub 2017 Dec 24.

11.

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group.

Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24.

12.

Survival of an AIDS patient after infection with Acanthamoeba sp. of the central nervous system.

El Sahly H, Udayamurthy M, Parkerson G, Hasbun R.

Infection. 2017 Oct;45(5):715-718. doi: 10.1007/s15010-017-1037-9. Epub 2017 Jun 21.

PMID:
28639141
13.

Arcanobacterium haemolyticum CNS abscess and bacteremia following head trauma: a case report and literature review.

Cortés-Penfield N, Kohli A, Weatherhead J, El Sahly H.

Infect Dis Clin Pract (Baltim Md). 2017 May;25(3):e9-e11. doi: 10.1097/IPC.0000000000000477.

14.

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.

Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB.

Vaccine. 2017 Mar 23;35(13):1675-1682. doi: 10.1016/j.vaccine.2017.02.032. Epub 2017 Feb 27.

PMID:
28256358
15.

Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.

Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM.

Vaccine. 2017 Feb 7;35(6):923-928. doi: 10.1016/j.vaccine.2016.12.053. Epub 2017 Jan 11.

PMID:
28089141
16.

Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature.

El Chaer F, Harris N, El Sahly H, Hemmige V, Martinez Blanco E, Woc-Colburn L.

Int J STD AIDS. 2016 Nov;27(13):1218-1222. Epub 2015 May 28. Review.

PMID:
26023092
17.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

18.

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR.

JAMA. 2015 Jul 21;314(3):237-46. doi: 10.1001/jama.2015.7916.

PMID:
26197184
19.

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.

Frey SE, Wald A, Edupuganti S, Jackson LA, Stapleton JT, El Sahly H, El-Kamary SS, Edwards K, Keyserling H, Winokur P, Keitel W, Hill H, Goll JB, Anderson EL, Graham IL, Johnston C, Mulligan M, Rouphael N, Atmar R, Patel S, Chen W, Kotloff K, Creech CB, Chaplin P, Belshe RB.

Vaccine. 2015 Sep 22;33(39):5225-34. doi: 10.1016/j.vaccine.2015.06.075. Epub 2015 Jul 2.

PMID:
26143613
20.

Gastrointestinal Coccidioidomycosis.

Weatherhead JE, Barrows BD, Stager CE, Finch CJ, El Sahly HM.

J Clin Gastroenterol. 2015 Aug;49(7):628-9. doi: 10.1097/MCG.0000000000000326. No abstract available.

PMID:
25887112
21.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Brady RC, Keitel WA, El Sahly H, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB.

Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.

22.

Ongoing epidemic of lymphogranuloma venereum in HIV-positive men who have sex with men: how symptoms should guide treatment.

Mohrmann G, Noah C, Sabranski M, Sahly H, Stellbrink HJ.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19657. doi: 10.7448/IAS.17.4.19657. eCollection 2014.

23.

Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults.

Bernstein DI, Jackson L, Patel SM, El Sahly HM, Spearman P, Rouphael N, Rudge TL Jr, Hill H, Goll JB.

Vaccine. 2014 Oct 29;32(47):6284-93. doi: 10.1016/j.vaccine.2014.08.076. Epub 2014 Sep 17.

24.

Performance of Xpert MTB/RIF in induced sputum samples at detecting Mycobacterium tuberculosis.

El Sahly HM.

Clin Infect Dis. 2014 Sep 15;59(6):911-2. doi: 10.1093/cid/ciu375. Epub 2014 May 22. No abstract available.

PMID:
24855147
25.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
26.

Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre.

El Sahly HM, Teeter LD, Musser JM, Graviss EA.

Clin Microbiol Infect. 2014 Mar;20(3):263-8. doi: 10.1111/1469-0691.12298. Epub 2013 Aug 24.

27.

High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.

Hoffmann C, Sahly H, Jessen A, Ingiliz P, Stellbrink HJ, Neifer S, Schewe K, Dupke S, Baumgarten A, Kuschel A, Krznaric I.

Infection. 2013 Oct;41(5):999-1003. doi: 10.1007/s15010-013-0501-4. Epub 2013 Jul 13.

PMID:
23852945
28.

Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised).

Keitel WA, Piedra PA, Atmar RL, Demmler G, El Sahly HM, Barrett J, Halpin RA, Lagos R, Fisher-Hoch S, Munoz F.

BMC Res Notes. 2013 May 3;6:177. doi: 10.1186/1756-0500-6-177.

29.

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.

Patel SM, Atmar RL, El Sahly HM, Guo K, Hill H, Keitel WA.

J Infect Dis. 2012 Oct 1;206(7):1069-77. doi: 10.1093/infdis/jis402. Epub 2012 Aug 13.

30.

Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA.

J Infect Dis. 2012 Mar 1;205(5):703-12. doi: 10.1093/infdis/jir837. Epub 2012 Jan 24.

31.

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M.

Vaccine. 2011 Oct 13;29(44):7733-9. doi: 10.1016/j.vaccine.2011.07.128. Epub 2011 Aug 9.

PMID:
21835220
32.

Safety and immunogenicity of a candidate parvovirus B19 vaccine.

Bernstein DI, El Sahly HM, Keitel WA, Wolff M, Simone G, Segawa C, Wong S, Shelly D, Young NS, Dempsey W.

Vaccine. 2011 Oct 6;29(43):7357-63. doi: 10.1016/j.vaccine.2011.07.080. Epub 2011 Jul 30.

33.

Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.

El Sahly HM, Teeter LD, Jost KC Jr, Dunbar D, Lew J, Graviss EA.

J Clin Microbiol. 2011 Aug;49(8):2942-5. doi: 10.1128/JCM.00231-11. Epub 2011 Jun 8.

34.

S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.

Andresen E, Lange C, Strodthoff D, Goldmann T, Fischer N, Sahly H, Branscheid D, Heine H.

BMC Pulm Med. 2011 Feb 15;11:10. doi: 10.1186/1471-2466-11-10.

35.

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.

El Sahly H.

Expert Rev Vaccines. 2010 Oct;9(10):1135-41. doi: 10.1586/erv.10.111. Review.

PMID:
20923265
36.

Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic.

El Sahly HM, Patel SM, Atmar RL, Lanford TA, Dube T, Thompson D, Sim BK, Long C, Keitel WA.

Clin Vaccine Immunol. 2010 Oct;17(10):1552-9. doi: 10.1128/CVI.00082-10. Epub 2010 Aug 11.

37.

Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps.

Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller E, Csernok E, Ambrosch P, Hellmich B, Moosig F, Gross WL, Sahly H, Lamprecht P.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):51-5.

PMID:
20412703
38.

[Diagnosis of infections in pneumology].

Strassburg A, Dalhoff K, Engelmann I, Ewig S, Herth FJ, Knobloch J, Rohde G, Sahly H, Schaaf B, Lange C.

Pneumologie. 2010 Aug;64(8):474-87. doi: 10.1055/s-0029-1244120. Epub 2010 May 20. Review. German. Erratum in: Pneumologie. 2010 Oct;64(10):631.

39.

[Diagnosis of infections in pneumology].

Strassburg A, Dalhoff K, Engelmann I, Ewig S, Herth FJ, Knobloch J, Rohde G, Sahly H, Schaaf B, Lange C.

Pneumologie. 2010 May;64(5):291-9. doi: 10.1055/s-0029-1243917. Epub 2010 May 7. Review. German.

40.

Monoclonal antibody S60-4-14 reveals diagnostic potential in the identification of Pseudomonas aeruginosa in lung tissues of cystic fibrosis patients.

Schmengler K, Goldmann T, Brade L, Sánchez Carballo PM, Albrecht S, Brade H, Kosma P, Sahly H, Hauber HP, Länger F, Meyer R, Welte T, Zähringer U.

Eur J Cell Biol. 2010 Jan;89(1):25-33. doi: 10.1016/j.ejcb.2009.10.010.

PMID:
20022136
41.

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.

Patel SM, Atmar RL, El Sahly HM, Cate TR, Keitel WA.

Vaccine. 2010 Apr 9;28(17):3025-9. doi: 10.1016/j.vaccine.2009.10.152. Epub 2009 Nov 18.

42.

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

Keitel WA, Treanor JJ, El Sahly HM, Gilbert A, Meyer AL, Patriarca PA, Cox MM.

Vaccine. 2009 Dec 11;28(2):379-85. doi: 10.1016/j.vaccine.2009.10.037. Epub 2009 Oct 29.

PMID:
19879222
43.

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA.

Vaccine. 2009 Aug 6;27(36):4905-11. doi: 10.1016/j.vaccine.2009.06.036. Epub 2009 Jun 28.

44.

Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.

Keitel WA, Treanor JJ, El Sahly HM, Evans TG, Kopper S, Whitlow V, Selinsky C, Kaslow DC, Rolland A, Smith LR, Lalor PA.

Hum Vaccin. 2009 Aug;5(8):536-44. Epub 2009 Aug 14.

45.

Manno(rhamno)biose-containing capsular polysaccharides of Klebsiella pneumoniae enhance opsono-stimulation of human polymorphonuclear leukocytes.

Sahly H, Keisari Y, Ofek I.

J Innate Immun. 2009;1(2):136-44. doi: 10.1159/000154812. Epub 2008 Sep 9.

46.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
47.

Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Aug;7(6):713-9. doi: 10.1586/14760584.7.6.713. Review.

PMID:
18665769
48.

Klebsiella oxytoca: opportunistic infections in laboratory rodents.

Bleich A, Kirsch P, Sahly H, Fahey J, Smoczek A, Hedrich HJ, Sundberg JP.

Lab Anim. 2008 Jul;42(3):369-75. doi: 10.1258/la.2007.06026e.

PMID:
18625592
49.

Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae.

Sahly H, Navon-Venezia S, Roesler L, Hay A, Carmeli Y, Podschun R, Hennequin C, Forestier C, Ofek I.

Antimicrob Agents Chemother. 2008 Sep;52(9):3029-34. doi: 10.1128/AAC.00010-08. Epub 2008 Jun 23.

50.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892

Supplemental Content

Support Center